Literature DB >> 8585713

MICs of 28 antibiotic compounds for 14 Bartonella (formerly Rochalimaea) isolates.

M Maurin1, S Gasquet, C Ducco, D Raoult.   

Abstract

We assessed in vitro the antibiotic susceptibilities of 14 Bartonella isolates of the species B. quintana, B. vinsonii, B. henselae, and B. elizabethae. Columbia agar base supplemented with 5% horse blood was used as the antibiotic assay medium. Bacterial growth could be evaluated within 5 days after incubation of the plates at 37 degrees C in a 5% carbon dioxide atmosphere. The MICs at which 90% of isolates are inhibited (MIC90s) were 0.06 microgram/ml for penicillin G and amoxicillin and 0.25 microgram/ml for ticarcillin and cefotaxime. The MIC90s of oxacillin and cephalothin were 4 and 16 micrograms/ml, respectively. The MIC90s ranged from 1 to 4 micrograms/ml for aminoglycosides. Erythromycin, doxycycline, and rifampin displayed MIC90s of 0.12, 0.12, and 0.25 microgram/ml, respectively. MIC90s were 1 and 5 micrograms/ml for trimethoprim-and sulfamethoxazole, respectively, 64 micrograms/ml for fosfomycin, and 16 micrograms/ml for colistin and vancomycin. The study confirms the high levels of in vitro susceptibility of Bartonella agents to antibiotics.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8585713      PMCID: PMC162952          DOI: 10.1128/AAC.39.11.2387

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  40 in total

1.  Role of erythrocytes and serum in the nutrition of Rickettsia quintana.

Authors:  W F Myers; L D Cutler; C L Wisseman
Journal:  J Bacteriol       Date:  1969-02       Impact factor: 3.490

2.  Accuracy of the KOH and vancomycin tests in determining the Gram reaction of non-enterobacterial rods.

Authors:  A von Graevenitz; C Bucher
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

3.  Cat-scratch disease. An overview based on a study of 1,200 patients.

Authors:  H A Carithers
Journal:  Am J Dis Child       Date:  1985-11

4.  In vitro susceptibility of Capnocytophaga strains to 18 antimicrobial agents.

Authors:  V L Sutter; D Pyeatt; Y Y Kwok
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

5.  Cutaneous vascular lesions and disseminated cat-scratch disease in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.

Authors:  J E Koehler; P E LeBoit; B M Egbert; T G Berger
Journal:  Ann Intern Med       Date:  1988-09-15       Impact factor: 25.391

6.  Antibiotic susceptibility patterns in Rochalimaea quintana, the agent of trench fever.

Authors:  W F Myers; D M Grossman; C L Wisseman
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

7.  In vitro cultivation of the rickettsial agent of trench fever.

Authors:  J W Vinson
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

8.  Vole agent identified as a strain of the trench fever rickettsia, Rochalimaea quintana.

Authors:  E Weiss; G A Dasch; D R Woodman; J C Williams
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

9.  Lack of bactericidal effect of antibiotics except aminoglycosides on Bartonella (Rochalimaea) henselae.

Authors:  D Musso; M Drancourt; D Raoult
Journal:  J Antimicrob Chemother       Date:  1995-07       Impact factor: 5.790

10.  Antibiotic therapy for cat-scratch disease?

Authors:  C W Bogue; J D Wise; G F Gray; K M Edwards
Journal:  JAMA       Date:  1989-08-11       Impact factor: 56.272

View more
  24 in total

Review 1.  Natural history of Bartonella infections (an exception to Koch's postulate).

Authors:  V Jacomo; P J Kelly; Didier Raoult
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

Review 2.  Use of aminoglycosides in treatment of infections due to intracellular bacteria.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

Review 3.  Current knowledge of Bartonella species.

Authors:  M Maurin; R Birtles; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-07       Impact factor: 3.267

Review 4.  Recommendations for treatment of human infections caused by Bartonella species.

Authors:  J M Rolain; P Brouqui; J E Koehler; C Maguina; M J Dolan; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

5.  Detection and culture of Bartonella quintana, Serratia marcescens, and Acinetobacter spp. from decontaminated human body lice.

Authors:  B La Scola; P E Fournier; P Brouqui; D Raoult
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

Review 6.  Optimum treatment of intracellular infection.

Authors:  M Maurin; D Raoult
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

7.  Intra-nodal injection of gentamicin for the treatment of suppurated cat scratch disease's lymphadenitis.

Authors:  Camille Garnier; Guillaume Martin-Blondel; Cécile Debuisson; Damien Dubois; Alexa Debard; Lise Cuzin; Patrice Massip; Pierre Delobel; Bruno Marchou
Journal:  Infection       Date:  2015-05-23       Impact factor: 3.553

8.  Bartonella (Rochalimaea) quintana infection in a seronegative hemodialyzed patient.

Authors:  M Drancourt; V Moal; P Brunet; B Dussol; Y Berland; D Raoult
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

9.  In vitro activities of telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, and Ehrlichia chaffeensis.

Authors:  J M Rolain; M Maurin; A Bryskier; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

10.  Genomic variation of Bartonella henselae strains detected in lymph nodes of patients with cat scratch disease.

Authors:  Zaher Zeaiter; Pierre-Edouard Fournier; Didier Raoult
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.